FY26 UDO initiative - illumina INC:1107104 [25-010024]
Ended Awarded Last action
- Contract number
- 75N90025F00016
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,837
Award facts
- Contract value 100% obligated
- $12,836.50 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a $12,836.50 firm fixed-price delivery order to Illumina, Inc. under the FY26 Unlimited Delivery Order (UDO) Initiative on September 24, 2025, with an ultimate completion date of October 23, 2025. This delivery order, issued without a set-aside designation, procures genetic sequencing products or services from Illumina's comprehensive portfolio, which includes next-generation sequencing instruments, reagents, consumables, and bioinformatics software. Illumina, a San Diego-based biotechnology company, serves as a specialized provider of genomic analysis technologies across multiple federal agencies and has maintained an extensive federal contracting history since its registration with the government in 2001.
This delivery order represents a continuation of the NIH Clinical Center's ongoing relationship with Illumina for genomic sequencing and analysis capabilities that support clinical research and diagnostic initiatives. The relatively modest ceiling value aligns with the typical scope of individual task orders issued under the USDA's $45 million indefinite delivery contract and other federal vehicles through which Illumina regularly supplies reagent kits, maintenance services, and consumables to support federal research operations. The firm fixed-price structure reflects Illumina's established market position as the primary viable source for proprietary sequencing systems and associated materials across federal civilian research agencies.
Quick answers
Who was awarded contract 75N90025F00016?
75N90025F00016 was awarded to Illumina, Inc. by NIH Clinical Center (National Institutes of Health) on September 24, 2025.
How much is contract 75N90025F00016 worth?
The government has obligated $12,837 on 75N90025F00016.
Is contract 75N90025F00016 an order under another contract?
Yes. 75N90025F00016 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N90025F00016 competed?
The extent of competition for 75N90025F00016 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award